Login / Signup
HER2 positive breast cancer patients having HER2 loss after neoadjuvant chemotherapy should still be treated with adjuvant anti-HER2 treatment.
Kadri Altundag
Published in:
Breast cancer research and treatment (2019)
Keyphrases
</>
neoadjuvant chemotherapy
positive breast cancer
end stage renal disease
newly diagnosed
ejection fraction
locally advanced
chronic kidney disease
lymph node
early stage
sentinel lymph node
squamous cell carcinoma
patient reported
replacement therapy